BACKGROUND: Preterm neonates are highly vulnerable to infection. OBJECTIVES: To investigate the developmental contribution of prematurity, chorioamnionitis and antenatal corticosteroids (ANS) on the maturation of neonatal microbial pathogen recognition responses. METHODS: Using standardized protocols, we assayed multiple inflammatory cytokine responses (IL-1β, IL-6, TNF-α and IL-12/23p40) to three prototypic Toll-like receptor (TLR) agonists, i.e. TLR4 (lipopolysaccharide), TLR5 (flagellin) and TLR7/8 (R848), and to the non-TLR retinoic acid-inducible gene I (RIG-I)-like receptor agonist, in cord blood mononuclear cells from neonates born before 33 weeks of gestation and at term. RESULTS: TLR responses develop asynchronously in preterm neonates, whereby responses to TLR7/8 were more mature and were followed by the development of TLR4 responses, which were also heterogeneous. Responses to TLR5 were weakest and most immature. Maturity in TLR responses was not influenced by sex. Overall, we detected no significant contribution of ANS and chorioamnionitis to the developmental attenuation of either TLR or RIG-I responses. CONCLUSIONS: The maturation of anti-microbial responses in neonates born early in gestation follows an asynchronous developmental hierarchy independently of an exposure to chorioamnionitis and ANS. Our data provide an immunological basis for the predominance of specific microbial infections in this age group.
BACKGROUND: Preterm neonates are highly vulnerable to infection. OBJECTIVES: To investigate the developmental contribution of prematurity, chorioamnionitis and antenatal corticosteroids (ANS) on the maturation of neonatal microbial pathogen recognition responses. METHODS: Using standardized protocols, we assayed multiple inflammatory cytokine responses (IL-1β, IL-6, TNF-α and IL-12/23p40) to three prototypic Toll-like receptor (TLR) agonists, i.e. TLR4 (lipopolysaccharide), TLR5 (flagellin) and TLR7/8 (R848), and to the non-TLR retinoic acid-inducible gene I (RIG-I)-like receptor agonist, in cord blood mononuclear cells from neonates born before 33 weeks of gestation and at term. RESULTS: TLR responses develop asynchronously in preterm neonates, whereby responses to TLR7/8 were more mature and were followed by the development of TLR4 responses, which were also heterogeneous. Responses to TLR5 were weakest and most immature. Maturity in TLR responses was not influenced by sex. Overall, we detected no significant contribution of ANS and chorioamnionitis to the developmental attenuation of either TLR or RIG-I responses. CONCLUSIONS: The maturation of anti-microbial responses in neonates born early in gestation follows an asynchronous developmental hierarchy independently of an exposure to chorioamnionitis and ANS. Our data provide an immunological basis for the predominance of specific microbial infections in this age group.
Authors: Praveen Ballabh; E S Lo; J Kumari; T B Cooper; I Zervoudakis; P A M Auld; A N Krauss Journal: Clin Pharmacol Ther Date: 2002-01 Impact factor: 6.875
Authors: A Kavelaars; G van der Pompe; J M Bakker; P M van Hasselt; B Cats; G H Visser; C J Heijnen Journal: Pediatr Res Date: 1999-03 Impact factor: 3.756
Authors: Boris W Kramer; Machiko Ikegami; Timothy J M Moss; Ilias Nitsos; John P Newnham; Alan H Jobe Journal: Am J Respir Crit Care Med Date: 2004-10-01 Impact factor: 21.405
Authors: Tobias R Kollmann; Juliet Crabtree; Annie Rein-Weston; Darren Blimkie; Francis Thommai; Xiu Yu Wang; Pascal M Lavoie; Jeff Furlong; Edgardo S Fortuno; Adeline M Hajjar; Natalie R Hawkins; Steven G Self; Christopher B Wilson Journal: J Immunol Date: 2009-11-16 Impact factor: 5.422
Authors: Ngoc P Ly; Begoña Ruiz-Pérez; Andrew B Onderdonk; Arthur O Tzianabos; Augusto A Litonjua; Catherine Liang; Daniel Laskey; Mary L Delaney; Andrea M DuBois; Hara Levy; Diane R Gold; Louise M Ryan; Scott T Weiss; Juan C Celedón Journal: Clin Mol Allergy Date: 2006-09-26
Authors: J Pagel; A Hartz; J Figge; C Gille; S Eschweiler; K Petersen; L Schreiter; J Hammer; C M Karsten; D Friedrich; E Herting; W Göpel; J Rupp; C Härtel Journal: Clin Exp Immunol Date: 2016-06-12 Impact factor: 4.330
Authors: Elizabeth A Marchant; Bernard Kan; Ashish A Sharma; Alice van Zanten; Tobias R Kollmann; Rollin Brant; Pascal M Lavoie Journal: Pediatr Res Date: 2015-07-17 Impact factor: 3.756
Authors: Emma de Jong; David G Hancock; Julie Hibbert; Christine Wells; Peter Richmond; Karen Simmer; David Burgner; Tobias Strunk; Andrew J Currie Journal: J Mol Med (Berl) Date: 2017-11-13 Impact factor: 4.599